Brett Faine

co-founder @EMPHARM_NET

[Megan Rech, PharmD, MS @MeganARech]

@bfaine1 & I penned an editorial called Pharmacists on the Front Lines: Advances in Emergency Medicine Pharmacy Practice on the history and advancement of EM pharmacy culminating in this EM themed issue🚨

https://t.co/GcMwfHPFQ8

[Megan Rech, PharmD, MS @MeganARech]

Excited to share the Emergency Medicine themed issue of @ASHPOfficial @AJHPOfficial that I guested edited w/ @bfaine1.

20 ( ‼️ ) papers & >50 EM pharmacists - this is a testament to how talented and diverse our EM pharmacy community is!

Read here 👉https://t.co/hh4Hxzwq4T

[Brett Faine @bfaine1]

I’m fortunate to have such talented friends. Big thanks to @LRayRx for giving the EM Research Division conference room a stylish upgrade. Check out his additional work at: https://t.co/j3D81ACpos

[Brett Faine @bfaine1]

@Dr_AzeemAhmed It has been a great ride. I will always value and appreciate your mentorship and friendship. #Titrate2life

[EMPHARM-NET @EMPHARM_NET]

🔥 New study HBV s/p sexual assault:

🏥 1010 patients, 10 @EMPHARM_NET EDs
💉 62.7 % with no/unknown vaccine history - only 5.8% received HBV vaccine
🧪 HBV serology testing 63.6%
🦠 8 patients received HBIG
🚨 Room for improvement in HBV care

Free link: https://t.co/oq0RgcRnsd

[EMPHARM-NET @EMPHARM_NET]

🔥 Off the Press: Risk factors for enterococcal UTI in ED patients (n=1836, 5% Enterococcus)

🧪 Combination of positive leukocyte esterase (LE+) and negative nitrite (NI−)  significantly associated w/ Enterococcus UTI (aOR 7.1, 95 % CI 3.73–13.5)

 https://t.co/5975lF1GFz

[Megan Rech, PharmD, MS @MeganARech]

🔥New @EMPHARM_NET DONT EXPAND Study:
💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140)
😷Desmo patients had higher baseline ICH volumes
🧠No difference in good or excellent hemostatic efficacy assessed via hematoma volume measures
https://t.co/E3Z0TC3QvY

[Ryan Feldman (empoisonpharmd.bsky.social) @EMPoisonPharmD]

🚨 Just published in AJEM from @EMPHARM_NET:

CuratED: The 2024 Emergency Medicine Drug Lit Review

🔥 11 RCTs
📜 10 guidelines
🔍 7 meta-analyses
💊 DAPT & stroke, steroids & CAP, TXA & ICH, Andexxa & more

Stay EM Pharm sharp👇
🔗 https://t.co/tejQKt6KQO

#FOAMed #MedED

[EMPHARM-NET @EMPHARM_NET]

Our COPY-ED study was highlighted in NEJM Journal Watch: https://t.co/eqkrxzYUjl

@bfaine1 @ThePeoplesRuben @giles_slocum @DEZ_EM_Pharm @gavin_howington @AM_EM_PharmD @annezepeski @MeganARech

[EMPHARM-NET @EMPHARM_NET]

🔥Hot off the press: @EMPHARM_NET COPY-ED Study:
💊 Oral cephalosporins (n=647) vs IDSA guideline concordant FQ or TMP-SMX (n=204) for pyelonephritis in patients discharged from the ED
🙅‍♀️No difference in 14 d treatment failure
@jlkoehl @bfaine1
https://t.co/NDZbMlv88A

[EMPHARM-NET @EMPHARM_NET]

🚨New @EMPHARM_NET pub in @AJHPOfficial 🚨
💊Survey of EM pharmacist (23% response rate; n=174)
💊94% reported epinephrine in accordance with ACLS
💊Ca, Mg and NaHCO3 common adjunctive meds
💊81% use norepinephrine as post-ROSC pressor of choice, 17% epi
https://t.co/pjmIUjOWz3

[Megan Rech, PharmD, MS @MeganARech]

Excited for all the great things in the works for EM pharmacists @AJHPOfficial
@bfaine1

Stay tuned 👀 @ASHP_EMPharm @accpemedprn @SAEM_AEMP @EMPHARM_NET

[EMPHARM-NET @EMPHARM_NET]

Our latest ⁦paper 🚑🚨: a systematic review comparing norepinephrine vs epinephrine for post-cardiac arrest shock 🫀⁦@Nimbex2001⁩ ⁦@bfaine1⁩ ⁦@MeganARech⁩ ⁦@CBthePHARMD⁩ ⁦@giles_slocum⁩ ⁦@nacquisto⁩ ⁦@LRayRx⁩ https://t.co/9J5GGoY3BP

[Megan Rech, PharmD, MS @MeganARech]

So heartened to see 130+ EM pharmacist/advocate volunteers for the @SAEMonline #AEMP interest group! Our community is so diverse, talented and eager, and we can’t wait to get started!

Learn more here 👉https://t.co/w6YfjZATsG

[Brett Faine @bfaine1]

@PharmD_intheED Interesting question but it lacks significant context to make an informed decision. What does “lead�� imply?

[Lance Ray @LRayRx]

Props to our research team @EMPHARM_NET lead by @MeganARech and @bfaine1 on top poster award at #SAEM23

[Brett Faine @bfaine1]

@MeganARech @GilbertPharmD @CBthePHARMD @EMPHARM_NET Unfortunately, we did not evaluate delirium in ED-SED.

[EMPHARM-NET @EMPHARM_NET]

Check out our brand new website where you can meet our team, 👩🏼‍⚕️see our current and past research 📄and reach out! Big thanks to our webmaster ⁦@gavin_howington for making this happen! 👏⁩
https://t.co/NGQTGgb3hV

[Brett Faine @bfaine1]

@EMPoisonPharmD Can you add an option for none of the above?

[Brett Faine @bfaine1]

@LRayRx Next time for sure. Always looking for a new pair!